Coding equipment trouble ahead; Chewy candy line boasts continuous dosing;

> As much as 80 percent of currently installed coding devices within the pharma and healthcare sectors may not meet upcoming legislative requirements for speed and quality. Story

> Bosch Packaging has unveiled a chewy candy production line that features a continuous dosing system and crystallizer. Bosch release

> Warning Letter 320-11-008 cites Teva in Petach Tikva, Israel, for inadequate investigation of a batch that failed due to impurities, for invalidating the results and for selectively using passing results from a different analysis to approve the lot. Warning Letter

> For a bioprocess productivity boost, key in on the metric where production time is consistently lost: product changeover. Article

> The FDA has cited Cephazone Pharma of Pomona, CA, for inappropriate lab tests for product sterility and for lack of control over systems confirming that changes in master production and other records are made only by authorized personnel. Warning Letter

> Aptuit will provide manufacturing scale-up services for Iroko's pain medications entering Phase III trials. Release

> Pro-Pharmaceuticals will work with custom manufacturer SAFC to enhance the manufacturing of bulk drug substance or API for cancer treatment Davanat. Item

> DHL's air and sea freight specialist has opened a Vienna Airport life sciences competence center that includes 500 square meters of refrigerated warehouse space. DHL release

> Some counterfeit drugs are made with equipment stolen from legitimate drug factories while others are made with custom equipment for counterfeits. Story

Suggested Articles

AbbVie will soon own Allergan’s prized Botox franchise, and along with its roughly $4 billion in sales, it will get a new $176 million plant.

Merck KGaA has big plans for a site in Switzerland where it intends to knit together biologics development and manufacturing. 

The FDA has found some issues with Biocon’s small molecule plant in Bengaluru, India.